Claim/exemption information - Registry number 11105

Correct administrative non-compliances.

Correct the disclosure of misleading information on suitable extinguishing media.

Correct the disclosure of misleading information regarding specific target organ toxicity.

Disclose a sufficient description of the delayed and immediate effects, and chronic effects from short-term and long-term exposure.

Disclose an ACGIH TLV–TWA of 0.1 ppm and ACGIH TLV–STEL of 0.3 ppm (DSEN, RSEN) exposure limits for the ingredient “formaldehyde”.

Disclose an adequate product odour.

Disclose the additional applicable common names and synonyms for the ingredients “toluene” and “butan-1-ol”.

Disclose the applicable information for “hazardous decomposition products” under section 10, “Stability and reactivity”.

Disclose the applicable information for “the most important symptoms and effects, both acute and delayed” under section 4, “First aid measures”.

Disclose the calculated product oral ATE value of 4 100 mg/kg (44% unknown), dermal ATE value of 43 000 mg/kg (44% unknown), and inhalation (vapour) value of 21 mg/L (44% unknown).

Disclose the hazard classifications of “Specific Target Organ Toxicity — Single Exposure) — Category 1 (central nervous system)”, “Specific Target Organ Toxicity — Single exposure — Category 3, narcotic effects (central nervous system)”, “Specific Target Organ Toxicity — Repeated Exposure — Category 1 (heart, kidney, lungs, liver, immune system, central nervous system)”, “Germ Cell Mutagenicity — Category 2”, “Carcinogenicity — Category 1”, and “Flammable Liquids — Category 1."

Disclose the information elements concerning the additional hazard and precautionary statements.

Disclose “Other hazards” on the SDS.